FibroBiologics will present on fibroblast-based therapies for chronic diseases at a conference in Freiburg, Germany, on March 27, 2025. FibroBiologics, Inc., a biotechnology company focused on ...
Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in excessive fibrosis, disfigurement, and long-term functional impairment. Researchers now report a ...
Human lung fibroblasts stimulated with TGF-β1 to detect extracellular collagen I (pink), alpha-smooth muscle actin (α-SMA) (green), and cell nuclei (blue) as a measure of matrix production and ...
Pelvic organ prolapse (POP) represents a highly prevalent condition among women, particularly following childbirth and during aging, with recurrence ...
This article is based on a poster originally authored by Fiona Leslie, Chloe Whiting, and Megan Webster. Idiopathic Pulmonary Fibrosis (IPF) is a chronic and progressive interstitial lung disease ...
Helmholtz Munich researchers revealed a conserved differentiation process with clinical implications for injury repair, identifying a multipotent fibroblast progenitor in the fascia— the deepest ...
FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Diabetic Foot Ulcer Trial to Initiate in 1H26 ...
Biomedical researchers have decoded how mechanical forces drive cell behavior in fibrosis. The cells in human bodies are subject to both chemical and mechanical forces. But up until recently, ...
CAFs Impact ECM and tumor growth: CAFs secrete MMPs to degrade ECM, releasing growth factors for cancer cells. ECM changes counteract CAFs and tumor cells: (a) Hard ECM triggers Twist release from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results